Literature DB >> 20935164

Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha.

Hong Lu1, Frank J Gonzalez, Curtis Klaassen.   

Abstract

Hepatocyte nuclear factor 4 alpha (HNF4a) is a liver-enriched master regulator of liver function. HNF4a is important in regulating hepatic expression of certain cytochrome P450s. The purpose of this study was to use mice lacking HNF4a expression in liver (HNF4a-HNull) to elucidate the role of HNF4a in regulating hepatic expression of phase II enzymes and transporters in mice. Compared with male wild-type mice, HNF4a-HNull male mouse livers had (1) markedly lower messenger RNAs (mRNAs) encoding the uptake transporters sodium taurocholate cotransporting polypeptide, organic anion transporting polypeptide (Oatp) 1a1, Oatp2b1, organic anion transporter 2, sodium phosphate cotransporter type 1, sulfate anion transporter 1, sodium-dependent vitamin C transporter 1, the phase II enzymes Uridine 5'-diphospho (UDP)-glucuronosyltransferase (Ugt) 2a3, Ugt2b1, Ugt3a1, Ugt3a2, sulfotransferase (Sult) 1a1, Sult1b1, Sult5a1, the efflux transporters multidrug resistance-associated protein (Mrp) 6, and multidrug and toxin extrusion 1; (2) moderately lower mRNAs encoding Oatp1b2, organic cation transporter (Oct) 1, Ugt1a5, Ugt1a9, glutathione S-transferase (Gst) m4, Gstm6, and breast cancer resistance protein; but (3) higher mRNAs encoding Oatp1a4, Octn2, Ugt1a1, Sult1e1, Sult2a2, Gsta4, Gstm1-m3, multidrug resistance protein (Mdr) 1a, Mrp3, and Mrp4. Hepatic signaling of nuclear factor E2-related factor 2 and pregnane X receptor appear to be activated in HNF4a-HNull mice. In conclusion, HNF4a deficiency markedly alters hepatic mRNA expression of a large number of phase II enzymes and transporters, probably because of the loss of HNF4a, which is a transactivator and a determinant of gender-specific expression and/or adaptive activation of signaling pathways important in hepatic regulation of these phase II enzymes and transporters.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935164      PMCID: PMC2984525          DOI: 10.1093/toxsci/kfq280

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  82 in total

1.  Tissue distribution and ontogeny of sulfotransferase enzymes in mice.

Authors:  Yazen Alnouti; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2006-06-28       Impact factor: 4.849

2.  Plasticity and expanding complexity of the hepatic transcription factor network during liver development.

Authors:  Irene Kyrmizi; Pantelis Hatzis; Nitsa Katrakili; Francois Tronche; Frank J Gonzalez; Iannis Talianidis
Journal:  Genes Dev       Date:  2006-08-15       Impact factor: 11.361

3.  Development of a fluorescent microsphere-based multiplexed high-throughput assay system for profiling of transcription factor activation.

Authors:  Takuro Yaoi; Xin Jiang; Xianqiang Li
Journal:  Assay Drug Dev Technol       Date:  2006-06       Impact factor: 1.738

4.  Pregnane X receptor is a target of farnesoid X receptor.

Authors:  Diana Jung; David J Mangelsdorf; Urs A Meyer
Journal:  J Biol Chem       Date:  2006-05-08       Impact factor: 5.157

5.  Endocrine regulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expression.

Authors:  Xingguo Cheng; Jonathan Maher; Hong Lu; Curtis D Klaassen
Journal:  Mol Pharmacol       Date:  2006-06-28       Impact factor: 4.436

6.  Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha.

Authors:  J M Maher; A L Slitt; T N Callaghan; X Cheng; C Cheung; F J Gonzalez; C D Klaassen
Journal:  Biochem Pharmacol       Date:  2006-03-30       Impact factor: 5.858

7.  HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression.

Authors:  Vanessa Douet; Christopher M VanWart; Matthew B Heller; Sabrina Reinhard; Olivier Le Saux
Journal:  Biochim Biophys Acta       Date:  2006-08-11

8.  Regulation of mRNA expression of xenobiotic transporters by the pregnane x receptor in mouse liver, kidney, and intestine.

Authors:  Xingguo Cheng; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2006-08-23       Impact factor: 3.922

9.  Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.

Authors:  Myong Suk Ko; Seung Jin Lee; Jin Wan Kim; Jee Woong Lim; Sang Geon Kim
Journal:  Drug Metab Dispos       Date:  2006-05-19       Impact factor: 3.922

10.  Signalling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b.

Authors:  Soo-Hee Park; Christopher A Wiwi; David J Waxman
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

View more
  19 in total

1.  Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha.

Authors:  Seema S Desai; Jason C Tung; Vivian X Zhou; James P Grenert; Yann Malato; Milad Rezvani; Regina Español-Suñer; Holger Willenbring; Valerie M Weaver; Tammy T Chang
Journal:  Hepatology       Date:  2016-03-09       Impact factor: 17.425

2.  Regulation of hepatic phase II metabolism in pregnant mice.

Authors:  Xia Wen; Ajay C Donepudi; Paul E Thomas; Angela L Slitt; Roberta S King; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2012-10-10       Impact factor: 4.030

3.  Molecular mechanisms underlying the enhanced functions of three-dimensional hepatocyte aggregates.

Authors:  Tammy T Chang; Millie Hughes-Fulford
Journal:  Biomaterials       Date:  2013-12-12       Impact factor: 12.479

4.  Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas.

Authors:  Michelle Kim; Perri Deacon; Rommel G Tirona; Richard B Kim; Christopher L Pin; Henriette E Meyer Zu Schwabedissen; Rennian Wang; Ute I Schwarz
Journal:  Histochem Cell Biol       Date:  2017-05-10       Impact factor: 4.304

5.  Inhibition of human UGT2B7 gene expression in transgenic mice by the constitutive androstane receptor.

Authors:  M F Yueh; P L Mellon; R H Tukey
Journal:  Mol Pharmacol       Date:  2011-03-17       Impact factor: 4.436

Review 6.  Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.

Authors:  Atsushi Yonezawa; Ken-ichi Inui
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

7.  Transcriptional Regulation of Solute Carrier (SLC) Drug Transporters.

Authors:  Shiwei Zhou; Yan Shu
Journal:  Drug Metab Dispos       Date:  2022-05-29       Impact factor: 3.579

Review 8.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

9.  Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.

Authors:  Kai Connie Wu; Julia Yue Cui; Curtis D Klaassen
Journal:  PLoS One       Date:  2012-07-12       Impact factor: 3.240

Review 10.  The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders.

Authors:  Kuo-Chen Wu; Chun-Jung Lin
Journal:  J Food Drug Anal       Date:  2018-12-04       Impact factor: 6.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.